398 related articles for article (PubMed ID: 34169710)
1. Multifunctional Selenium Quantum Dots for the Treatment of Alzheimer's Disease by Reducing Aβ-Neurotoxicity and Oxidative Stress and Alleviate Neuroinflammation.
Guo X; Lie Q; Liu Y; Jia Z; Gong Y; Yuan X; Liu J
ACS Appl Mater Interfaces; 2021 Jul; 13(26):30261-30273. PubMed ID: 34169710
[TBL] [Abstract][Full Text] [Related]
2. Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer's Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota.
Li C; Wang N; Zheng G; Yang L
ACS Appl Mater Interfaces; 2021 Oct; 13(39):46406-46420. PubMed ID: 34569225
[TBL] [Abstract][Full Text] [Related]
3. A Functionalized Octahedral Palladium Nanozyme as a Radical Scavenger for Ameliorating Alzheimer's Disease.
Jia Z; Yuan X; Wei JA; Guo X; Gong Y; Li J; Zhou H; Zhang L; Liu J
ACS Appl Mater Interfaces; 2021 Oct; 13(42):49602-49613. PubMed ID: 34641674
[TBL] [Abstract][Full Text] [Related]
4. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
Xie Y; Tan Y; Zheng Y; Du X; Liu Q
J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
6. Current Strategies for Modulating Aβ Aggregation with Multifunctional Agents.
Du Z; Li M; Ren J; Qu X
Acc Chem Res; 2021 May; 54(9):2172-2184. PubMed ID: 33881820
[TBL] [Abstract][Full Text] [Related]
7. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
8. Screening of Synthetic Isoxazolone Derivative Role in Alzheimer's Disease: Computational and Pharmacological Approach.
Ali M; Saleem U; Anwar F; Imran M; Nadeem H; Ahmad B; Ali T; Atta-Ur-Rehman ; Ismail T
Neurochem Res; 2021 Apr; 46(4):905-920. PubMed ID: 33486698
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective Potential of Curcumin-Loaded Nanostructured Lipid Carrier in an Animal Model of Alzheimer's Disease: Behavioral and Biochemical Evidence.
Sadegh Malvajerd S; Izadi Z; Azadi A; Kurd M; Derakhshankhah H; Sharifzadeh M; Akbari Javar H; Hamidi M
J Alzheimers Dis; 2019; 69(3):671-686. PubMed ID: 31156160
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
11. AMPK: Potential Therapeutic Target for Alzheimer's Disease.
Yang L; Jiang Y; Shi L; Zhong D; Li Y; Li J; Jin R
Curr Protein Pept Sci; 2020; 21(1):66-77. PubMed ID: 31424367
[TBL] [Abstract][Full Text] [Related]
12. Screening of treatment targets for Alzheimer's disease from the molecular mechanisms of impairment by β-amyloid aggregation and tau hyperphosphorylation.
Lin LF; Luo HM
Neurosci Bull; 2011 Feb; 27(1):53-60. PubMed ID: 21270904
[TBL] [Abstract][Full Text] [Related]
13. A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease.
Singh YP; Rai H; Singh G; Singh GK; Mishra S; Kumar S; Srikrishna S; Modi G
Eur J Med Chem; 2021 Apr; 215():113278. PubMed ID: 33662757
[TBL] [Abstract][Full Text] [Related]
14. Management of oxidative stress and other pathologies in Alzheimer's disease.
Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
[TBL] [Abstract][Full Text] [Related]
15. Amorphous nano-selenium quantum dots prevent pulmonary arterial hypertension through recoupling endothelial nitric oxide synthase.
Zhu ML; Gao ZT; Lu JX; Wang Y; Wang G; Zhu TT; Li P; Liu C; Wang SX; Yang L
Aging (Albany NY); 2020 Dec; 13(3):3368-3385. PubMed ID: 33323558
[TBL] [Abstract][Full Text] [Related]
16. Ginkgo biloba Extract EGb761 Attenuates Hyperhomocysteinemia-induced AD Like Tau Hyperphosphorylation and Cognitive Impairment in Rats.
Zeng K; Li M; Hu J; Mahaman YAR; Bao J; Huang F; Xia Y; Liu X; Wang Q; Wang JZ; Yang Y; Liu R; Wang X
Curr Alzheimer Res; 2018; 15(1):89-99. PubMed ID: 28847282
[TBL] [Abstract][Full Text] [Related]
17. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
[TBL] [Abstract][Full Text] [Related]
18. Unravelling the in vitro and in vivo potential of selenium nanoparticles in Alzheimer's disease: A bioanalytical review.
Vicente-Zurdo D; Rosales-Conrado N; León-González ME
Talanta; 2024 Mar; 269():125519. PubMed ID: 38086100
[TBL] [Abstract][Full Text] [Related]
19. Oleocanthal enhances amyloid-β clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model.
Qosa H; Batarseh YS; Mohyeldin MM; El Sayed KA; Keller JN; Kaddoumi A
ACS Chem Neurosci; 2015 Nov; 6(11):1849-59. PubMed ID: 26348065
[TBL] [Abstract][Full Text] [Related]
20. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
